Edition:
United States

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

4.13USD
15 Dec 2017
Change (% chg)

$0.02 (+0.49%)
Prev Close
$4.11
Open
$4.14
Day's High
$4.26
Day's Low
$4.11
Volume
18,388
Avg. Vol
36,857
52-wk High
$21.86
52-wk Low
$3.60

Latest Key Developments (Source: Significant Developments)

Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​
Monday, 4 Dec 2017 04:43pm EST 

Dec 4 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​.  Full Article

Apollo Endosurgery Receives FDA Clearance For Overstitch Sx Endoscopic Suturing System
Monday, 27 Nov 2017 04:01pm EST 

Nov 27 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY RECEIVES FDA CLEARANCE FOR OVERSTITCH™ SX ENDOSCOPIC SUTURING SYSTEM.APOLLO ENDOSURGERY INC - ‍U.S. FOOD AND DRUG ADMINISTRATION 510K CLEARANCE OF OVERSTITCH SX​.APOLLO ENDOSURGERY INC - ‍PLANS TO INTRODUCE SX SYSTEM IN US AND EUROPE IN FIRST HALF OF 2018​.  Full Article

Apollo Endosurgery reports qtrly loss per share $‍0.32​
Thursday, 26 Oct 2017 04:01pm EDT 

Oct 26 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery Inc reports third quarter 2017 results.Q3 sales $16.5 million versus I/B/E/S view $16.7 million.Apollo Endosurgery Inc - qtrly loss per share $‍0.32​.  Full Article

Apollo endosurgery announces CE mark approval for the Orbera365™ managed weight loss system,
Wednesday, 30 Aug 2017 04:01pm EDT 

Aug 31 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery announces CE mark approval for the Orbera365™ managed weight loss system, expanding the indwell period from 6 months to 12 months with the gastric balloon category leader.Apollo Endosurgery Inc - ‍Company expects Orbera365 to be commercially available starting in Q4 of 2017​.Apollo Endosurgery - ‍Approval enables Apollo to market and sell Orbera365 weight loss balloon in European Union and European economic area member countries​.  Full Article

Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc
Friday, 18 Aug 2017 05:30pm EDT 

Aug 18 (Reuters) - Stonepine Capital Management LLC::Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc as of August 11, 2017 - SEC filing‍​.  Full Article

Novo Holdings A/S reports 3.9 pct stake in Apollo Endosurgery as on Aug 14
Wednesday, 16 Aug 2017 04:34pm EDT 

Aug 16 (Reuters) - Apollo Endosurgery Inc :Novo Holdings A/S reports 3.9 percent stake in Apollo Endosurgery Inc as on August 14, 2017 - SEC filing‍​.Novo Holdings A/S had previously reported 6.3 percent stake in Apollo Endosurgery Inc as on August 10, 2017.  Full Article

Apollo Endosurgery Q2 revenue $17.1 mln
Tuesday, 1 Aug 2017 04:01pm EDT 

Aug 1 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery reports second quarter 2017 results.Q2 revenue $17.1 million.Apollo Endosurgery - total endo-bariatric revenues were $9.5 million for three months ended june 30, 2017, an increase of 13.0% compared to q2 of 2016.Qtrly loss per share $0.64.  Full Article

Apollo Endosurgery files amended S-1 registration statement
Wednesday, 12 Jul 2017 09:32am EDT 

July 12 (Reuters) - Apollo Endosurgery Inc ::Files amended S-1 registration statement, sees offering of 3.5 million shares of its common stock - SEC filing.Apollo Endosurgery says it estimates the net proceeds of offering will be about $24.3 million.  Full Article

Apollo Endosurgery sees Q2 total revenue to be $16.9 mln to $17.1 mln
Wednesday, 12 Jul 2017 05:45am EDT 

July 12 (Reuters) - Apollo Endosurgery Inc ::Apollo Endosurgery Inc reports preliminary unaudited financial estimates for the second quarter of 2017.Sees Q2 non-GAAP revenue up 2 to 4 percent .Total GAAP revenue is estimated to be in range of $16.9 million to $17.1 million for three months ended June 30, 2017​.Preliminary total non-gaap revenue is estimated to be in range of $16.6 million to $16.8 million for three months ended June 30, 2017.Sees preliminary total gaap operating loss to be in range of $5.5 million to $6.0 million for three months ended June 30, 2017.  Full Article

Apollo Endosurgery Q1 revenue falls 10 pct to $14.6 mln
Thursday, 4 May 2017 06:15am EDT 

May 4 (Reuters) - Apollo Endosurgery Inc ::Q1 revenue fell 10 percent to $14.6 million.Qtrly loss per share $0.77.  Full Article

BRIEF-Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​

* APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​ Source text (http://bit.ly/2AONduG) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)